US 10221414
Compositions for modulating C9ORF72 expression
granted A61PA61P25/00A61P25/16
Quick answer
US patent 10221414 (Compositions for modulating C9ORF72 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61P, A61P25/00, A61P25/16, A61P25/28